Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended September 30, 2019
October 11, 2019 08:00 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Oct. 11, 2019 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, today reported preliminary gross sales results of $7.0...
Emmaus Life Sciences Granted Patent in India for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis
October 09, 2019 07:30 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the allowance by the Indian Patent Office of...